Could regenerative medicine therapy help with arthritis in the spine?

Degenerative disc disease of the spine is a painful yet all too common problem for many people. It can manifest as pain in the hips, buttocks, and even sometimes down the leg. However, the source of this problem lies in the spine.

Spinal arthritis surgery is not only a long and painful process, but it’s also extremely expensive—one of the most expensive orthopedic surgeries in 2019.

(This surgery, on the low end, can cost around $75,000 and can even reach up to $125,000 after a hospital stay pre-op and post-operative care!)

Additionally, there is often more considerable downtime and recovery with traditional surgical methods, which much of the working population simply cannot afford.

Luckily, there are alternative treatments for arthritis in the spine for those who are candidates.

Is there an alternative to spinal arthritis surgery?

Motus Bio offers neck and back pain treatments in Kansas City for those suffering arthritis in the spine, herniated discs, and other ailments.

We use mesenchymal cells (from a patient’s own body) as a natural alternative to traditional spinal surgery. Our regenerative treatments can help you manage your neck and back pain. This is an exciting area of medicine and renowned institutions such as the Mayo Clinic are performing additional research studies.

Are cellular therapies permanent?

While mesenchymal cells are not a permanent solution to spinal arthritis, it can provide much needed relief to patients who are experiencing aches and pains.

In general, regenerative medicine treatments for chronic conditions (such as arthritis) are truly temporary solutions to “kick the can down the road.”

Patients have varying reasons why they want to avoid surgery. Many have comorbidities such as uncontrolled diabetes, morbid obesity, chronic kidney/liver/heart disease, a history of postoperative infection or clotting (DVT – deep venous thrombosis or PE – pulmonary embolism), adverse reaction to anesthesia, and metal allergy.

These patients may be deemed as not being candidates for surgery. Many individuals want to avoid the risk (however small) of heart attack or stroke, bleeding, and infection.

We find that the younger candidates want to delay surgery for as long as possible or until they reach 65 when Medicare would cover a vast majority of the cost.

What other questions do you have about regenerative medicine treatments?

Motus Biologics is here to be your online resource for all-things regenerative medicine. Please don’t hesitate to contact us and we’ll be happy to discuss your options with you.

You can also use our free Virtual Consultation tool to determine the best treatment for your pain points.



general contact